Background: The worldwide prevalence of metabolic syndrome (MS) and obesity has led to the exploration of tea consumption as a potential strategy for managing these conditions. However, the clinical outcomes remain debated. We conducted a meta-analysis to evaluate the benefits of tea supplementation in MS and obesity entirely based on randomized controlled trials (RCTs). Methods: Databases of PubMed, Cochrane library, MEDLINE and Web of Science were searched through May 2023 to identify eligible RCTs evaluating the effects of tea supplementation related to MS and obesity. Results were summariz...
